Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2014, Vol. 15 Issue (8): 756-760    DOI: 10.1631/jzus.B1400100
Case Reports     
Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy
You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, Yi-cheng Chen, Kang-xin Ni, Ming-chao Wang, Wei-ping Zhao, Faisal Rehman, Shaw P. Wan, Gong-hui Li
Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China; Department of Urology, the First People's Hospital of Xiaoshan, Hangzhou 311200, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: It is recommended that transurethral resection of the prostate (TURP) after brachytherapy should not be performed at an early stage after implantation. Herein we report our experiences and the results of channel TURP (cTURP) within six months post-implant for patients with refractory urinary retention. Methods: One hundred and ninety patients with localized prostate cancer of clinical stages T1c to T2c were treated by brachytherapy as monotherapy at our institution from February 2009 to July 2013. Nine patients who developed refractory urinary retention and underwent cTURP within six months after brachytherapy were retrospectively reviewed and analyzed. Results: The median interval between prostate brachytherapy and cTURP was three months (range 1.5 to 5.0 months). There were no intraoperative or postoperative complications and no incontinence resulting from the surgery. All urinary retention was relieved per the American Brachytherapy Society urinary symptom score. With a mean follow-up time of 16 months (range 6 to 26 months) after cTURP, no patient experienced biochemical recurrence. The mean serum prostate-specific antigen (PSA) of the patients who underwent cTURP was 0.42 ng/ml (range 0.08 to 0.83 ng/ml) at the end of their follow-up. Conclusions: Early cTURP was found to be safe and effective in relieving urinary retention after brachytherapy and could be performed without compromising its therapeutic efficacy.

Key wordsProstate cancer      Brachytherapy      Transurethral resection of the prostate (TURP)     
Received: 14 April 2014      Published: 05 August 2014
CLC:  R69  
Cite this article:

You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, Yi-cheng Chen, Kang-xin Ni, Ming-chao Wang, Wei-ping Zhao, Faisal Rehman, Shaw P. Wan, Gong-hui Li. Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(8): 756-760.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1400100     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2014/V15/I8/756

[1] Juliana Felgueiras, Joana Vieira Silva, Margarida Fardilha. Prostate cancer: the need for biomarkers and new therapeutic targets[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 16-42.
[2] BALACHANDAR V., LAKSHMAN KUMAR B., SASIKALA K., MANIKANTAN P., SANGEETHA R., MOHANA DEVI S.. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(9): 638-646.
[3] Liu Ai-jun, Furusato Bungo, Ravindranath Lakshmi, Chen Yong-mei, Srikantan Vasanta, Mcleod David G., Petrovics Gyorgy, Srivastava Shiv. Quantitative analysis of a panel of gene expression in prostate cancer—with emphasis on NPY expression analysis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2007, 8(12): 853-859.